| Product Code: ETC13131518 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa PCR-based Infectious Diseases Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa PCR-based Infectious Diseases Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa PCR-based Infectious Diseases Market Revenues & Volume, 2021 & 2031F |
3.3 Africa PCR-based Infectious Diseases Market - Industry Life Cycle |
3.4 Africa PCR-based Infectious Diseases Market - Porter's Five Forces |
3.5 Africa PCR-based Infectious Diseases Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa PCR-based Infectious Diseases Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 Africa PCR-based Infectious Diseases Market Revenues & Volume Share, By Infection, 2021 & 2031F |
3.8 Africa PCR-based Infectious Diseases Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.9 Africa PCR-based Infectious Diseases Market Revenues & Volume Share, By PCR Technology, 2021 & 2031F |
3.10 Africa PCR-based Infectious Diseases Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.11 Africa PCR-based Infectious Diseases Market Revenues & Volume Share, By Testing, 2021 & 2031F |
3.12 Africa PCR-based Infectious Diseases Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Africa PCR-based Infectious Diseases Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa PCR-based Infectious Diseases Market Trends |
6 Africa PCR-based Infectious Diseases Market, 2021 - 2031 |
6.1 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Test Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Tuberculosis PCR Test, 2021 - 2031 |
6.1.3 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Hepatitis PCR Test, 2021 - 2031 |
6.1.4 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Human Immunodeficiency Virus (HIV) PCR Test, 2021 - 2031 |
6.1.5 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Influenza PCR Test, 2021 - 2031 |
6.1.6 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Human Papilloma Virus (HPV) PCR Test, 2021 - 2031 |
6.2 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Infection, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Viral Infection, 2021 - 2031 |
6.2.3 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Respiratory Tract Infection, 2021 - 2031 |
6.2.4 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Sexually Transmitted Infection, 2021 - 2031 |
6.2.5 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Hospital Acquired Infections, 2021 - 2031 |
6.2.6 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Other Infections, 2021 - 2031 |
6.3 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Viral, 2021 - 2031 |
6.3.3 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Bacterial, 2021 - 2031 |
6.3.4 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Fungal, 2021 - 2031 |
6.3.5 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Protozoa, 2021 - 2031 |
6.3.6 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By PCR Technology, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By RT PCR, 2021 - 2031 |
6.4.3 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Multiplex PCR, 2021 - 2031 |
6.4.4 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Geriatric, 2021 - 2031 |
6.5.3 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Pediatric, 2021 - 2031 |
6.5.4 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Adults, 2021 - 2031 |
6.6 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Testing, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Laboratory Based Testing, 2021 - 2031 |
6.6.3 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Point of Care Testing, 2021 - 2031 |
6.7 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.7.3 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Hospital, 2021 - 2031 |
6.7.4 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Academic and Research Institutes, 2021 - 2031 |
6.7.5 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Community Health Centers, 2021 - 2031 |
6.7.6 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.7.7 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Home Healthcare, 2021 - 2031 |
6.7.8 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Others, 2021 - 2031 |
7 Africa PCR-based Infectious Diseases Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.1 South Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.2 Egypt PCR-based Infectious Diseases Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.3 Nigeria PCR-based Infectious Diseases Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.4 Rest of Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.3 Africa PCR-based Infectious Diseases Market Revenues & Volume Share, By Infection, 2021 & 2031F |
7.3.1 South Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Infection, 2021 - 2031 |
7.3.2 Egypt PCR-based Infectious Diseases Market, Revenues & Volume, By Infection, 2021 - 2031 |
7.3.3 Nigeria PCR-based Infectious Diseases Market, Revenues & Volume, By Infection, 2021 - 2031 |
7.3.4 Rest of Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Infection, 2021 - 2031 |
7.4 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
7.4.1 South Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
7.4.2 Egypt PCR-based Infectious Diseases Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
7.4.3 Nigeria PCR-based Infectious Diseases Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
7.4.4 Rest of Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
7.5 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By PCR Technology, 2021 - 2031 |
7.5.1 South Africa PCR-based Infectious Diseases Market, Revenues & Volume, By PCR Technology, 2021 - 2031 |
7.5.2 Egypt PCR-based Infectious Diseases Market, Revenues & Volume, By PCR Technology, 2021 - 2031 |
7.5.3 Nigeria PCR-based Infectious Diseases Market, Revenues & Volume, By PCR Technology, 2021 - 2031 |
7.5.4 Rest of Africa PCR-based Infectious Diseases Market, Revenues & Volume, By PCR Technology, 2021 - 2031 |
7.6 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.1 South Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.2 Egypt PCR-based Infectious Diseases Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.3 Nigeria PCR-based Infectious Diseases Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.4 Rest of Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.7 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Testing, 2021 - 2031 |
7.7.1 South Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Testing, 2021 - 2031 |
7.7.2 Egypt PCR-based Infectious Diseases Market, Revenues & Volume, By Testing, 2021 - 2031 |
7.7.3 Nigeria PCR-based Infectious Diseases Market, Revenues & Volume, By Testing, 2021 - 2031 |
7.7.4 Rest of Africa PCR-based Infectious Diseases Market, Revenues & Volume, By Testing, 2021 - 2031 |
7.8 Africa PCR-based Infectious Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.1 South Africa PCR-based Infectious Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.2 Egypt PCR-based Infectious Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.3 Nigeria PCR-based Infectious Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.4 Rest of Africa PCR-based Infectious Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Africa PCR-based Infectious Diseases Market Key Performance Indicators |
9 Africa PCR-based Infectious Diseases Market - Export/Import By Countries Assessment |
10 Africa PCR-based Infectious Diseases Market - Opportunity Assessment |
10.1 Africa PCR-based Infectious Diseases Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa PCR-based Infectious Diseases Market Opportunity Assessment, By Test Type, 2021 & 2031F |
10.3 Africa PCR-based Infectious Diseases Market Opportunity Assessment, By Infection, 2021 & 2031F |
10.4 Africa PCR-based Infectious Diseases Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10.5 Africa PCR-based Infectious Diseases Market Opportunity Assessment, By PCR Technology, 2021 & 2031F |
10.6 Africa PCR-based Infectious Diseases Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
10.7 Africa PCR-based Infectious Diseases Market Opportunity Assessment, By Testing, 2021 & 2031F |
10.8 Africa PCR-based Infectious Diseases Market Opportunity Assessment, By End User, 2021 & 2031F |
11 Africa PCR-based Infectious Diseases Market - Competitive Landscape |
11.1 Africa PCR-based Infectious Diseases Market Revenue Share, By Companies, 2022 |
11.2 Africa PCR-based Infectious Diseases Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here